AQP4 and myeloid sarcoma: MOGAD is increasingly recognized as a distinct disease entity different from multiple sclerosis (MS) and aquaporin-4 (AQP4)-positive neuromyelitis optica spectrum disorder (NMOSD) and is more prevalent among children and young adults.